Genomictree Inc. (KOSDAQ:228760)
South Korea · Delayed Price · Currency is KRW 13,870
-990 (-6.66%)
Aug 12, 2026, 3:30 PM KST
Genomictree Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 364,464 | 659,414 | 490,598 | 486,819 | 181,477 | 270,356 | |
Market Cap Growth | 0.09% | 34.41% | 0.78% | 168.25% | -32.88% | -7.66% |
Enterprise Value | 289,442 | 576,582 | 396,622 | 392,442 | 88,761 | 154,638 |
Last Close Price | 14860.00 | 27450.00 | 20450.00 | 20600.00 | 8790.00 | 13300.00 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PS Ratio | 95.28 | 175.37 | 207.68 | 142.43 | 6.08 | 52.60 |
PB Ratio | 2.95 | 5.72 | 3.95 | 3.89 | 1.69 | 2.35 |
P/TBV Ratio | 2.99 | 5.79 | 4.00 | 3.95 | 1.72 | 2.39 |
P/FCF Ratio | - | - | - | - | 71.93 | - |
P/OCF Ratio | - | - | - | - | 42.35 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 75.67 | 153.34 | 167.90 | 114.82 | 2.97 | 30.09 |
EV/EBITDA Ratio | - | - | - | - | 23.73 | - |
EV/EBIT Ratio | - | - | - | - | 36.90 | - |
EV/FCF Ratio | - | - | - | - | 35.18 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0 | 0.02 | 0.02 | 0.02 | 0.27 | 0.33 |
Debt / EBITDA Ratio | - | - | - | - | 7.80 | - |
Debt / FCF Ratio | - | - | - | - | 11.57 | - |
Net Debt / Equity Ratio | -0.61 | -0.65 | -0.76 | -0.73 | -0.79 | -0.80 |
Net Debt / EBITDA Ratio | 7.89 | 7.33 | 6.65 | 5.66 | -22.84 | 10.43 |
Net Debt / FCF Ratio | 5.61 | 5.81 | 5.83 | 8.21 | -33.86 | 4.95 |
Asset Turnover | 0.03 | 0.03 | 0.02 | 0.02 | 0.18 | 0.04 |
Inventory Turnover | 9.46 | 10.21 | 7.48 | 6.57 | 10.63 | 3.48 |
Quick Ratio | 56.05 | 17.55 | 20.35 | 17.77 | 2.17 | 62.01 |
Current Ratio | 56.88 | 17.75 | 20.56 | 18.06 | 2.21 | 62.71 |
Return on Equity (ROE) | -6.67% | -7.62% | -8.33% | -7.75% | -5.60% | -10.86% |
Return on Assets (ROA) | -5.22% | -5.62% | -7.26% | -7.31% | 0.88% | -4.17% |
Return on Capital Employed (ROCE) | -8.50% | -9.70% | -12.20% | -13.60% | 2.20% | -5.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -2.20% | -1.36% | -2.09% | -1.80% | -3.65% | -4.23% |
FCF Yield | -3.69% | -1.96% | -3.28% | -2.28% | 1.39% | -6.88% |
Buyback Yield / Dilution | -0.37% | -0.56% | 9.93% | -26.28% | -1.68% | -3.30% |